Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(2):92-93; doi:10.1093/jnci/97.2.92
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Redesigning NCI's Clinical Trials System: Integration Is the Goal

Caroline McNeil

The first 10% of the full text of this article appears below.

Should there be a national tumor tissue bank? Should there be core facilities that trial investigators can access for biostatistics resources, image analysis, and other kinds of support? Should government, universities, and drug companies develop a single contract template to cover most clinical trial issues?

These questions and two dozen others are under active discussion in the National Cancer Institute's clinical trials working group (CTWG), the committee charged with redesigning the NCI's clinical trial system. The questions are posted on a new . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?